Role of ADAR1 loss in lung cancer on anti-tumor immunity and tumor cell growth via the RIG-I/MDA5-MAVS pathway. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced a strategic partnership with Hamamatsu Photonics K.K., a global leader in optical imaging technology. This ...

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

In the 460-million-year-old Eriptychius, the researchers found large, open pulp cavities and branching dentin tubules — an ...

Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...